Literature DB >> 3177368

IgD multiple myeloma: a cure at 21 years.

R A Kyle1.   

Abstract

A 52-year-old man with a plasmacytoma of the body of T-10 in February 1965 returned 6 months later with multiple myeloma characterized by bone pain, osteolytic lesions, and IgD lambda monoclonal protein in the serum, 6.1 g of Bence Jones protein in the urine, and 21% plasma cells in the bone marrow. The M-protein and bone pain disappeared within 6 weeks after therapy with melphalan and prednisone was started. Therapy was discontinued in December 1974. Immunoelectrophoreses and immunofixations of the serum and urine over the years revealed no monoclonal protein. A mediastinal tumor developed, and the patient died of respiratory insufficiency on October 23, 1986. Autopsy revealed a large bronchogenic carcinoma of the right lung extending to the mediastinum, trachea, and esophagus. There was no evidence of multiple myeloma. This patient had responded rapidly to chemotherapy and had no recurrence of myeloma during a 21-year follow-up.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3177368     DOI: 10.1002/ajh.2830290110

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  3 in total

1.  Robert Arthur Kyle, MD: a conversation with the editor.

Authors:  Robert Arthur Kyle; William Clifford Roberts
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-10

2.  IgD multiple myeloma with thoracic spine compression due to epidural extra-osseous tumour spread.

Authors:  Y I Lolin; C W Lam; W H Lo; K L Au; J R Masarei
Journal:  J Clin Pathol       Date:  1994-07       Impact factor: 3.411

3.  IgD multiple myeloma a descriptive report of 17 cases: survival and response to therapy.

Authors:  Francesco Pisani; Maria Teresa Petrucci; Diana Giannarelli; Velia Bongarzoni; Marco Montanaro; Valerio De Stefano; Giacinto La Verde; Fabiana Gentilini; Anna Levi; Tommaso Za; Alessandro Moscetti; Luciana Annino; Maria Concetta Petti
Journal:  J Exp Clin Cancer Res       Date:  2012-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.